Armando Anido

Biography

 Mr. Armando Anido, MBA, has been the Chairman and Chief Executive Officer of Zynerba Pharmaceuticals, Inc. since October 2014. Mr. Anido has more than 30 years of executive, operational and commercial leadership experience in the biopharmaceutical industry and he launched over 10 prescription medications in several therapeutic areas. He has broad understanding of key issues in the biotechnology industry, including sales and marketing, development and commercialization, strategy and operations and has extensive executive experience in senior leadership and director roles at several biotechnology companies. Prior to joining Zynerba, he served as a business consultant to the life science industry from May 2014 to October 2014. He served as the Chief Executive Officer at NuPathe, Inc., from July 25, 2012 to March 2014. He served as the Chief Executive and President of Auxilium Pharmaceuticals Inc. from July 17, 2006 to December 7, 2011. Mr. Anido joined Auxilium in 2006 and grew sales from $42M in 2005, to over $260M in 2011, increasing market capitalization from $200M to over $900M. He served as the Executive Vice President of Sales and Marketing of MedImmune, LLC (alternate name MedImmune Inc.) from February 22, 2005 to January 5, 2006 and its Senior Vice President of Commercial Operations from February 2004 to February 2005 and Senior Vice President of Sales and Marketing since 1999. He served as the Chairman of the Commercial Strategy Team at MedImmune, Inc. and was responsible for the commercial management of its marketed brands. He held several senior marketing positions at GlaxoWellcome, Inc. and its predecessor companies.

Research Interest

 business